The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex

Jie Yao Xiao, Gisselle Vélez Ruiz, Matthew Whorton, Søren G F Rasmussen, Brian T. DeVree, Xavier Deupi, Roger K. Sunahara, Brian Kobilka

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

G protein-coupled receptors (GPCRs) mediate the majority of physiologic responses to hormones and neurotransmitters. However, many GPCRs exhibit varying degrees of agonist-independent G protein activation. This phenomenon is referred to as basal or constitutive activity. For many of these GPCRs, drugs classified as inverse agonists can suppress basal activity. There is a growing body of evidence that basal activity is physiologically relevant, and the ability of a drug to inhibit basal activity may influence its therapeutic properties. However, the molecular mechanism for basal activation and inhibition of basal activity by inverse agonists is poorly understood and difficult to study, because the basally active state is short-lived and represents a minor fraction of receptor conformations. Here, we investigate basal activation of the G protein Gs by the β2 adrenergic receptor (β 2AR) by using purified receptor reconstituted into recombinant HDL particles with a stoichiometric excess of Gs. The β2AR is site-specifically labeled with a small, environmentally sensitive fluorophore enabling direct monitoring of agonist- and Gs-induced conformational changes. In the absence of an agonist, the β2AR and Gs can be trapped in a complex by enzymatic depletion of guanine nucleotides. Formation of the complex is enhanced by the agonist isoproterenol, and it rapidly dissociates on exposure to concentrations of GTP and GDP found in the cytoplasm. The inverse agonist ICI prevents formation of the β2AR-Gs complex, but has little effect on preformed complexes. These results provide insights into G protein-induced conformational changes in the β2AR and the structural basis for ligand efficacy.

Original languageEnglish (US)
Pages (from-to)9501-9506
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume106
Issue number23
DOIs
StatePublished - Jun 9 2009
Externally publishedYes

Fingerprint

G-Protein-Coupled Receptors
GTP-Binding Proteins
Adrenergic Receptors
Ligands
Adrenergic Agonists
Guanine Nucleotides
Guanosine Triphosphate
Isoproterenol
Pharmaceutical Preparations
Neurotransmitter Agents
Cytoplasm
Hormones
Therapeutics

Keywords

  • Adrenergic
  • Conformation
  • Constitutive activity
  • Inverse agonist
  • Receptor

ASJC Scopus subject areas

  • General

Cite this

The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. / Xiao, Jie Yao; Ruiz, Gisselle Vélez; Whorton, Matthew; Rasmussen, Søren G F; DeVree, Brian T.; Deupi, Xavier; Sunahara, Roger K.; Kobilka, Brian.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 23, 09.06.2009, p. 9501-9506.

Research output: Contribution to journalArticle

Xiao, Jie Yao ; Ruiz, Gisselle Vélez ; Whorton, Matthew ; Rasmussen, Søren G F ; DeVree, Brian T. ; Deupi, Xavier ; Sunahara, Roger K. ; Kobilka, Brian. / The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106, No. 23. pp. 9501-9506.
@article{ba2dd119abc64be19af6ddf1fe07a9ea,
title = "The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex",
abstract = "G protein-coupled receptors (GPCRs) mediate the majority of physiologic responses to hormones and neurotransmitters. However, many GPCRs exhibit varying degrees of agonist-independent G protein activation. This phenomenon is referred to as basal or constitutive activity. For many of these GPCRs, drugs classified as inverse agonists can suppress basal activity. There is a growing body of evidence that basal activity is physiologically relevant, and the ability of a drug to inhibit basal activity may influence its therapeutic properties. However, the molecular mechanism for basal activation and inhibition of basal activity by inverse agonists is poorly understood and difficult to study, because the basally active state is short-lived and represents a minor fraction of receptor conformations. Here, we investigate basal activation of the G protein Gs by the β2 adrenergic receptor (β 2AR) by using purified receptor reconstituted into recombinant HDL particles with a stoichiometric excess of Gs. The β2AR is site-specifically labeled with a small, environmentally sensitive fluorophore enabling direct monitoring of agonist- and Gs-induced conformational changes. In the absence of an agonist, the β2AR and Gs can be trapped in a complex by enzymatic depletion of guanine nucleotides. Formation of the complex is enhanced by the agonist isoproterenol, and it rapidly dissociates on exposure to concentrations of GTP and GDP found in the cytoplasm. The inverse agonist ICI prevents formation of the β2AR-Gs complex, but has little effect on preformed complexes. These results provide insights into G protein-induced conformational changes in the β2AR and the structural basis for ligand efficacy.",
keywords = "Adrenergic, Conformation, Constitutive activity, Inverse agonist, Receptor",
author = "Xiao, {Jie Yao} and Ruiz, {Gisselle V{\'e}lez} and Matthew Whorton and Rasmussen, {S{\o}ren G F} and DeVree, {Brian T.} and Xavier Deupi and Sunahara, {Roger K.} and Brian Kobilka",
year = "2009",
month = "6",
day = "9",
doi = "10.1073/pnas.0811437106",
language = "English (US)",
volume = "106",
pages = "9501--9506",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "23",

}

TY - JOUR

T1 - The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex

AU - Xiao, Jie Yao

AU - Ruiz, Gisselle Vélez

AU - Whorton, Matthew

AU - Rasmussen, Søren G F

AU - DeVree, Brian T.

AU - Deupi, Xavier

AU - Sunahara, Roger K.

AU - Kobilka, Brian

PY - 2009/6/9

Y1 - 2009/6/9

N2 - G protein-coupled receptors (GPCRs) mediate the majority of physiologic responses to hormones and neurotransmitters. However, many GPCRs exhibit varying degrees of agonist-independent G protein activation. This phenomenon is referred to as basal or constitutive activity. For many of these GPCRs, drugs classified as inverse agonists can suppress basal activity. There is a growing body of evidence that basal activity is physiologically relevant, and the ability of a drug to inhibit basal activity may influence its therapeutic properties. However, the molecular mechanism for basal activation and inhibition of basal activity by inverse agonists is poorly understood and difficult to study, because the basally active state is short-lived and represents a minor fraction of receptor conformations. Here, we investigate basal activation of the G protein Gs by the β2 adrenergic receptor (β 2AR) by using purified receptor reconstituted into recombinant HDL particles with a stoichiometric excess of Gs. The β2AR is site-specifically labeled with a small, environmentally sensitive fluorophore enabling direct monitoring of agonist- and Gs-induced conformational changes. In the absence of an agonist, the β2AR and Gs can be trapped in a complex by enzymatic depletion of guanine nucleotides. Formation of the complex is enhanced by the agonist isoproterenol, and it rapidly dissociates on exposure to concentrations of GTP and GDP found in the cytoplasm. The inverse agonist ICI prevents formation of the β2AR-Gs complex, but has little effect on preformed complexes. These results provide insights into G protein-induced conformational changes in the β2AR and the structural basis for ligand efficacy.

AB - G protein-coupled receptors (GPCRs) mediate the majority of physiologic responses to hormones and neurotransmitters. However, many GPCRs exhibit varying degrees of agonist-independent G protein activation. This phenomenon is referred to as basal or constitutive activity. For many of these GPCRs, drugs classified as inverse agonists can suppress basal activity. There is a growing body of evidence that basal activity is physiologically relevant, and the ability of a drug to inhibit basal activity may influence its therapeutic properties. However, the molecular mechanism for basal activation and inhibition of basal activity by inverse agonists is poorly understood and difficult to study, because the basally active state is short-lived and represents a minor fraction of receptor conformations. Here, we investigate basal activation of the G protein Gs by the β2 adrenergic receptor (β 2AR) by using purified receptor reconstituted into recombinant HDL particles with a stoichiometric excess of Gs. The β2AR is site-specifically labeled with a small, environmentally sensitive fluorophore enabling direct monitoring of agonist- and Gs-induced conformational changes. In the absence of an agonist, the β2AR and Gs can be trapped in a complex by enzymatic depletion of guanine nucleotides. Formation of the complex is enhanced by the agonist isoproterenol, and it rapidly dissociates on exposure to concentrations of GTP and GDP found in the cytoplasm. The inverse agonist ICI prevents formation of the β2AR-Gs complex, but has little effect on preformed complexes. These results provide insights into G protein-induced conformational changes in the β2AR and the structural basis for ligand efficacy.

KW - Adrenergic

KW - Conformation

KW - Constitutive activity

KW - Inverse agonist

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=67249125561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249125561&partnerID=8YFLogxK

U2 - 10.1073/pnas.0811437106

DO - 10.1073/pnas.0811437106

M3 - Article

C2 - 19470481

AN - SCOPUS:67249125561

VL - 106

SP - 9501

EP - 9506

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23

ER -